«The benefit we saw was remarkably consistent across the individual components of the endpoint and in all
the major subgroups of patients,» said Marc S. Sabatine, M.D., M.P.H., chair of the TIMI Study Group, a senior physician in the Cardiovascular Division at Brigham and Women's Hospital and Harvard Medical School in Boston, and the study's principal investigator.
Clinical features
of major depressive disorder (MDD) may help identify specific
subgroups of depressed
patients based on associations with genetic risk for
major psychiatric disorders, reports a study in Biological Psychiatry.